Precision Medicine

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 3
gptkbp:bfsParent gptkb:Research_Institute
gptkbp:advocates_for gptkb:hospital
gptkb:physicist
Policy makers
gptkbp:aims_to Patient outcomes
gptkbp:applies_to gptkb:Cardiovascular_diseases
Cancer treatment
Rare diseases
gptkbp:collaborated_with gptkb:physicist
Healthcare providers
Technology companies
gptkbp:defines An innovative approach to tailoring disease treatment and prevention strategies to individual characteristics.
gptkbp:focuses_on Environmental factors
Lifestyle choices
Genetic information
https://www.w3.org/2000/01/rdf-schema#label Precision Medicine
gptkbp:involves Personalized therapies
Targeted drug development
gptkbp:is_adopted_by Pharmaceutical industry
Healthcare systems
Insurance providers
gptkbp:is_challenged_by Ethical concerns
Access to technology
Data privacy issues
Regulatory hurdles
Public understanding
Clinical implementation barriers
gptkbp:is_evaluated_by Cost-effectiveness
Patient satisfaction
Clinical outcomes
gptkbp:is_explored_in Genetic testing
Biomarker discovery
Disease prevention strategies
gptkbp:is_influenced_by Lifestyle factors
Family history
Patient genetics
gptkbp:is_promoted_by gptkb:National_Institutes_of_Health_(NIH)
Research institutions
Pharmaceutical companies
gptkbp:is_related_to gptkb:Company
Clinical trials
Pharmacogenomics
gptkbp:is_supported_by gptkb:Artificial_Intelligence
gptkb:Government_initiatives
Data analytics
Public health organizations
Patient advocacy groups
Advances in genomics
gptkbp:utilizes Biomarkers
Genomic data